TITLE:
The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients

CONDITION:
Mycobacterium Avium-intracellular Infection

INTERVENTION:
Clarithromycin

SUMMARY:

      To determine whether clarithromycin is safe and effective in preventing disseminated
      Mycobacterium avium Complex in HIV-infected patients with CD4 counts <= 100 cells/mm3.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 12 Years to N/A
Criteria:

        Inclusion Criteria

        Patients must have:

          -  HIV infection.

          -  CD4 count <= 100 cells/mm3.

          -  No evidence of MAC.

          -  Life expectancy of at least 6 months.

        Exclusion Criteria

        Concurrent Medication:

        Excluded:

          -  Certain restricted drugs (details not available).

        Patients with the following prior conditions are excluded:

        History of allergy or hypersensitivity to macrolides. Active substance abuse or other
        conditions that would affect study compliance.
      
